---
figid: PMC7393681__nihms-1590529-f0002
figtitle: More RAS vulnerabilities, downstream
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7393681
filename: nihms-1590529-f0002.jpg
figlink: pmc/articles/PMC7393681/figure/F2/
number: F2
caption: Insight into additional aspects of RAS protein and pathway regulation reveal
  more ways to potentially target RAS. Biancucci et al. showed that endopeptidase
  RRSP modification of RAS (I) impairs its interaction with downstream kinase RAF.
  Looking further downstream still, Blake et al. applied a MYC degradation screen
  to identify the kinase CDK9 as a positive regulator of MYC protein stability (II)
  and, consequently, cell growth and survival. Some clinically approved therapeutics
  indicated for targeting RAS activation and signaling in cancer are noted (red).
papertitle: 'RAS, wanted dead or alive: Advances in targeting RAS-mutant cancers.'
reftext: Clint A Stalnecker, et al. Sci Signal. ;13(624):eaay6013.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9591116
figid_alias: PMC7393681__F2
figtype: Figure
redirect_from: /figures/PMC7393681__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7393681__nihms-1590529-f0002.html
  '@type': Dataset
  description: Insight into additional aspects of RAS protein and pathway regulation
    reveal more ways to potentially target RAS. Biancucci et al. showed that endopeptidase
    RRSP modification of RAS (I) impairs its interaction with downstream kinase RAF.
    Looking further downstream still, Blake et al. applied a MYC degradation screen
    to identify the kinase CDK9 as a positive regulator of MYC protein stability (II)
    and, consequently, cell growth and survival. Some clinically approved therapeutics
    indicated for targeting RAS activation and signaling in cancer are noted (red).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Akt
  - Mtor
  - Tor
  - Erk7
  - rl
  - oc
  - oo
  - Myc
  - Cdk9
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - MYC
  - CDK9
  - Encorafenib
  - Dabrafenib
  - Vemurafenib
  - Binimetinib
  - Cobimetinib
  - Trametinib
  - Everolimus
  - H Sirolimus
  - Temsirolimus
  - DOO OO OO
  - Ser
---
